|4Mar 28, 4:35 PM ET

Roka BioScience, Inc. 4

4 · Roka BioScience, Inc. · Filed Mar 28, 2017

Insider Transaction Report

Form 4
Period: 2017-03-24
Boesgaard Lars
Vice President, CFO
Transactions
  • Award

    Common stock, par value $0.001 per share

    2017-03-24+54,00054,000 total
    Exercise: $3.45Exp: 2027-03-23Common Stock (54,000 underlying)
Footnotes (1)
  • [F1]Such stock options vest 25% on March 24, 2018 and in twelve equal increments on a quarterly basis beginning three months after that. The stock options have a term of ten years.

Documents

1 file
  • 4
    wf-form4_149073329751227.xmlPrimary

    FORM 4